Ibogaine and the Brain Factory
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Ibogaine and the Brain Factory
-
ナレーター：
-
著者：
概要
This podcast episode discuss ibogaine, a psychoactive alkaloid derived from African plants that shows significant potential for treating addiction, PTSD, and traumatic brain injuries. Unlike traditional maintenance drugs, ibogaine acts as a "neurological reboot" by interrupting withdrawal symptoms and fostering deep psychological introspection. Recent clinical research, specifically the Stanford MISTIC protocol, demonstrates that co-administering magnesium can mitigate the substance's primary risk of cardiac toxicity. Advanced neuroimaging indicates that the treatment facilitates a "posterior shift" in brain waves, allowing the mind to release rigid trauma loops and repair damaged neural circuits. While it remains a Schedule I substance in the United States, recent federal executive orders and state-funded initiatives in Texas are accelerating the development of pharmaceutical analogs. These synthetic versions aim to preserve the medicine’s restorative benefits while eliminating its long hallucinogenic duration and heart risks. #ibogaine #psychedelic